Open

A study to test BI 764198 in people with a type of kidney disease called focal segmental glomerulosclerosis

This study is being done to see if the study drug, called BI 764198, may help people with your type of kidney disease called "FSGS" or focal segmental glomerulosclerosis. If you join this study, you may receive the study drug being tested BI 764198, or a placebo.

Age & Gender

18 years ~ 75 years
Male, Female, Gender Inclusive

Visit Availability

Standard business hours (M-F, 8-5)
Extended hours (M-F, early morning or evening)
In-home visits available
Visits can be combined with regular clinical appointments

Location

North Carolina (Statewide)

What will be asked of you

You will be asked to take a pill each day for 12 weeks. At each study visit we will take your blood pressure, obtain blood and urine samples, and perform a physical exam. You will have an eye exam at the beginning and end of the study. We would also like for you to keep a study drug diary to write down how you are feeling.

Incentives

You may receive up to $1,425 for your participation, Gas reimbursement

In-person visits:
8

Phone or online visits:
3

Total length of participation:
12-15 weeks

Looking for Specific Volunteers

Able to participate:

You have had a kidney biopsy and were diagnosed with FSGS or Focal Segmental Glomerulosclerosis

Not eligible if:

Have not received a diagnosis of FSGS
Have uncontrolled hypertension

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Primary Visit Location

Clinical and Translational Research Center (CTRC)
Burnett-Womack Building (UNC-Chapel Hill)
160 Dental Cir, Chapel Hill, NC 27514, USA

Secondary Visit Location

Clinical Research Unit
UNC Eastowne Medical Office Building
100 Eastowne Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Vimal Derebail
Medicine-Nephrology

Study Type

Clinical or Medical
Interventional

Study Topics

Kidneys and Liver

IRB Number

23-0530

ClinicalTrials.gov

NCT05213624

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.